{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:17:08Z","timestamp":1788509828258,"version":"build-2803163510"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Perioperative myocardial ischaemia-reperfusion injury continues to represent a significant source of morbidity and mortality in patients undergoing cardiac surgery, despite considerable advances in cardiopulmonary bypass technology and operative technique. Contemporary cardioprotective approaches, including cardioplegia, offer only partial attenuation of this injury. Intraoperative protection strategies have evolved little over recent decades, and clinical trials investigating pharmacological agents directed at ischaemia-reperfusion pathways have yielded inconsistent results, though subgroup analyses frequently reveal benefit in specific patient populations. Such variability may reflect the inherent limitations of applying standardised interventions to physiologically diverse patient cohorts. Multi-omics profiling offers the capacity to identify distinct molecular signatures associated with susceptibility to ischaemia-reperfusion injury and severity of myocardial damage, and when combined with artificial intelligence, may predict individual therapeutic responses. These bioinformatic advances have implications not only for risk stratification and treatment selection but also for the design of future clinical trials through improved patient selection. This review synthesises current evidence regarding the mechanisms of ischaemia-reperfusion injury and evaluates pharmacological interventions targeting mitochondrial dysfunction, microvascular impairment, and inflammatory pathways. The potential role of multi-omics technologies integrated with artificial intelligence in enabling precision approaches to myocardial protection is subsequently examined.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1844417","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:57:03Z","timestamp":1788508623000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological strategies for myocardial protection in cardiac surgery: current science and the emerging role of multi-omics and artificial intelligence"],"prefix":"10.3389","volume":"13","author":[{"given":"Hanad","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, Royal Papworth Hospital","place":["Cambridge, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Royal Papworth Hospital","place":["Cambridge, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.31083\/j.rcm2510355","article-title":"The value of biomarkers in major cardiovascular surgery necessitating cardiopulmonary bypass","volume":"25","author":"Stef","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1093\/eurheartj\/ehx383","article-title":"ESC Joint working groups on cardiovascular surgery and the cellular biology of the heart position paper: perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery","volume":"38","author":"Thielmann","year":"2017","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cvr\/cvp110","article-title":"The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia\/reperfusion damage","volume":"83","author":"Beyersdorf","year":"2009","journal-title":"Cardiovasc Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","article-title":"Cell biology of ischemia\/reperfusion injury","volume":"298","author":"Kalogeris","year":"2012","journal-title":"Int Rev Cell Mol Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1089253211436350","article-title":"Myocardial ischemia reperfusion injury: from basic science to clinical bedside","volume":"16","author":"Frank","year":"2012","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"B6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3978\/j.issn.2225-319X.2013.11.10","article-title":"Custodiol for myocardial protection and preservation: a systematic review","volume":"2","author":"Edelman","year":"2013","journal-title":"Ann Cardiothorac Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1051\/ject\/201244098","article-title":"History and use of del nido cardioplegia solution at Boston children\u2019s hospital","volume":"44","author":"Matte","year":"2012","journal-title":"J Extra Corpor Technol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41390-025-04021-0","article-title":"Genomics and multiomics in the age of precision medicine","volume":"97","author":"Mani","year":"2025","journal-title":"Pediatr Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-00477-1","article-title":"Systems biology in cardiovascular disease: a multiomics approach","volume":"18","author":"Joshi","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/biomedicines13071532","article-title":"Network pharmacology approaches to myocardial infarction reperfusion injury: exploring mechanisms, pathophysiology, and novel therapies","volume":"13","author":"Das","year":"2025","journal-title":"Biomedicines"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning","volume":"120","author":"Heusch","year":"2017","journal-title":"Circ Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1111\/bph.12975","article-title":"Redox signalling and cardioprotection: translatability and mechanism","volume":"172","author":"Pagliaro","year":"2015","journal-title":"Br J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00395-006-0584-5","article-title":"Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation","volume":"101","author":"Penna","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/CIR.0000000000001154","article-title":"Considerations on the management of acute postoperative ischaemia after cardiac surgery: a scientific statement from the American Heart Association","volume":"148","author":"Gaudino","year":"2023","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1042\/BSR20253410","article-title":"Myocardial stunning: mechanisms, molecular insights, and gaps in knowledge","volume":"45","author":"Al-Awar","year":"2025","journal-title":"Biosci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e676","DOI":"10.1161\/CIR.0000000000001133","article-title":"Atrial fibrillation occurring during acute hospitalization: a scientific statement from the American Heart Association","volume":"147","author":"Chyou","year":"2023","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1001\/jama.2025.14891","article-title":"Long-term continuous monitoring of new-onset atrial fibrillation after coronary artery bypass grafting","volume":"334","author":"Herrmann","year":"2025","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.amjcard.2010.03.032","article-title":"Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy","volume":"106","author":"Turer","year":"2010","journal-title":"Am J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/ALN.0000000000000331","article-title":"Cyclosporine protects the heart during aortic valve surgery","volume":"121","author":"Chiari","year":"2014","journal-title":"Anesthesiology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1476-5381.2011.01700.x","article-title":"Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent","volume":"165","author":"Hausenloy","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/heartjnl-2013-304845","article-title":"The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial","volume":"100","author":"Hausenloy","year":"2014","journal-title":"Heart"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1681\/ASN.2012121216","article-title":"The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin","volume":"24","author":"Birk","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/cells8070728","article-title":"Role of cardiolipin in mitochondrial function and dynamics in health and disease: molecular and pharmacological aspects","volume":"8","author":"Paradies","year":"2019","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s42003-020-1101-3","article-title":"The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats","volume":"3","author":"Allen","year":"2020","journal-title":"Commun Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e005487","DOI":"10.1161\/CIRCINTERVENTIONS.117.005487","article-title":"Phase 2a clinical trial of mitochondrial protection (elamipretide) during stent revascularization in patients with atherosclerotic renal artery stenosis","volume":"10","author":"Saad","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e004389","DOI":"10.1161\/CIRCHEARTFAILURE.117.004389","article-title":"Novel mitochondria-targeting peptide in heart failure treatment: a randomized, placebo-controlled trial of elamipretide","volume":"10","author":"Daubert","year":"2017","journal-title":"Circ Heart Fail"},{"key":"B28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jacbts.2018.12.005","article-title":"Elamipretide improves mitochondrial function in the failing human heart","volume":"4","author":"Chatfield","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1186\/s12967-023-04763-7","article-title":"Mitochondrion-targeted carboxymethyl chitosan hybrid nanoparticles loaded with coenzyme Q10 protect cardiac grafts against cold ischaemia-reperfusion injury in heart transplantation","volume":"21","author":"Yuan","year":"2023","journal-title":"J Transl Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"165768","DOI":"10.1016\/j.bbadis.2020.165768","article-title":"Mitochondrial ROS in myocardial ischemia reperfusion and remodeling","volume":"1866","author":"Bugger","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.healun.2015.05.007","article-title":"The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model","volume":"34","author":"Dare","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12192-022-01273-1","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorates myocardial ischemia-reperfusion injury by enhancing PINK1\/parkin-mediated mitophagy in type 2 diabetic rats","volume":"27","author":"Ji","year":"2022","journal-title":"Cell Stress Chaperones"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1096\/fj.05-3718com","article-title":"Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury","volume":"19","author":"Adlam","year":"2005","journal-title":"FASEB J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jtcvs.2004.03.034","article-title":"Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue","volume":"129","author":"Rosenfeldt","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/j.jvca.2008.03.007","article-title":"The role of oral coenzyme Q10 in patients undergoing coronary artery bypass graft surgery","volume":"22","author":"Makhija","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B36","doi-asserted-by":"publisher","first-page":"15514","DOI":"10.18632\/aging.103742","article-title":"Ubiquinol supplementation in elderly patients undergoing aortic valve replacement: biochemical and clinical aspects","volume":"12","author":"Orlando","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/icvts\/ivu334","article-title":"Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis","volume":"20","author":"De Frutos","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/jcm11082233","article-title":"No-reflow phenomenon: a contemporary review","volume":"11","author":"Annibali","year":"2022","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/anae.14577","article-title":"Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass","volume":"74","author":"Dekker","year":"2019","journal-title":"Anaesthesia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13054-020-02948-w","article-title":"Microcirculatory perfusion disturbances following cardiopulmonary bypass: a systematic review","volume":"24","author":"Den Os","year":"2020","journal-title":"Crit Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1053\/j.jvca.2013.05.026","article-title":"Microcirculatory perfusion is preserved during off-pump but not on-pump cardiac surgery","volume":"28","author":"Koning","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B42","doi-asserted-by":"publisher","first-page":"10891","DOI":"10.3390\/ijms252010891","article-title":"The crucial triad: endothelial glycocalyx, oxidative stress, and inflammation in cardiac surgery: exploring the molecular connections","volume":"25","author":"\u0106urko-Cofek","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mvr.2019.02.004","article-title":"Correlation between acute degradation of the endothelial glycocalyx and microcirculation dysfunction during cardiopulmonary bypass in cardiac surgery","volume":"124","author":"Wu","year":"2019","journal-title":"Microvasc Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2337\/diabetes.55.02.06.db05-1103","article-title":"Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo","volume":"55","author":"Nieuwdorp","year":"2006","journal-title":"Diabetes"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/nm.2022","article-title":"Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery","volume":"15","author":"Yemisci","year":"2009","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature13165","article-title":"Capillary pericytes regulate cerebral blood flow in health and disease","volume":"508","author":"Hall","year":"2014","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e29280","DOI":"10.7554\/eLife.29280","article-title":"Capillary pericytes mediate coronary no-reflow after myocardial ischaemia","volume":"6","author":"O'Farrell","year":"2017","journal-title":"eLife"},{"key":"B48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/biomedicines13010033","article-title":"Prolonged cardiopulmonary bypass time-induced endothelial dysfunction via glypican-1 shedding, inflammation, and matrix metalloproteinase 9 in patients undergoing cardiac surgery","volume":"13","author":"Li","year":"2024","journal-title":"Biomedicines"},{"key":"B49","doi-asserted-by":"publisher","first-page":"104381","DOI":"10.1016\/j.mvr.2022.104381","article-title":"Doxycycline can reduce glycocalyx shedding by inhibiting matrix metalloproteinases in patients undergoing cardiopulmonary bypass: a randomised controlled trial","volume":"142","author":"Gao","year":"2022","journal-title":"Microvasc Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1053\/j.jvca.2025.09.232","article-title":"Effect of dexmedetomidine on endothelial glycocalyx in patients undergoing cardiac surgery with cardiopulmonary bypass","volume":"40","author":"Fan","year":"2026","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1110532","DOI":"10.3389\/fmed.2023.1110532","article-title":"Microvascular dysfunction following cardiopulmonary bypass plays a central role in postoperative organ dysfunction","volume":"10","author":"Kant","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1161\/01.CIR.100.13.1438","article-title":"Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass","volume":"100","author":"Lazar","year":"1999","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"II274","DOI":"10.1161\/01.CIR.0000138315.99788.eb","article-title":"Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass","volume":"110","author":"Lazar","year":"2004","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.21037\/jtd-24-295","article-title":"Elevated circulating levels of neutrophil extracellular traps after cardiopulmonary bypass surgery as risk factors of postoperative atrial fibrillation and mortality","volume":"16","author":"Jung","year":"2024","journal-title":"J Thorac Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"19249","DOI":"10.1038\/s41598-019-55863-8","article-title":"Targeting of cell-free DNA by DNase I diminishes endothelial dysfunction and inflammation in a rat model of cardiopulmonary bypass","volume":"9","author":"Weber","year":"2019","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13054-023-04341-9","article-title":"The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial","volume":"27","author":"Pan","year":"2023","journal-title":"Crit Care"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1161\/CIRCULATIONAHA.111.026153","article-title":"Colchicine reduces postoperative atrial fibrillation: results of the colchicine for the prevention of the postpericardiotomy syndrome (COPPS) atrial fibrillation substudy","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","author":"Imazio","year":"2014","journal-title":"JAMA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"euad169","DOI":"10.1093\/europace\/euad169","article-title":"Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials","volume":"25","author":"Agarwal","year":"2023","journal-title":"Europace"},{"key":"B60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjcard.2024.09.003","article-title":"Colchicine in patients with coronary disease who underwent coronary artery bypass surgery: a meta-analysis of randomized controlled trials","volume":"231","author":"Kirov","year":"2024","journal-title":"Am J Cardiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00380-005-0873-1","article-title":"Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery","volume":"21","author":"Orhan","year":"2006","journal-title":"Heart Vessels"},{"key":"B62","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.avsg.2008.12.005","article-title":"Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass","volume":"23","author":"Prabhu","year":"2009","journal-title":"Ann Vasc Surg"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e0213862","DOI":"10.1371\/journal.pone.0213862","article-title":"N-acetylcysteine use among patients undergoing cardiac surgery: a systematic review and meta-analysis of randomized trials","volume":"14","author":"Pereira","year":"2019","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"795839","DOI":"10.3389\/fmed.2022.795839","article-title":"Efficacy of N-acetylcysteine in preventing acute kidney injury and major adverse cardiac events after cardiac surgery: a meta-analysis and trial sequential analysis","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/FJC.0000000000001551","article-title":"N-acetylcysteine to reduce mortality for patients requiring cardiac catheterization or cardiac surgery: a systematic review and meta-analysis","volume":"83","author":"Gakuba","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.athoracsur.2007.01.003","article-title":"Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery","volume":"84","author":"Liakopoulos","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"B67","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ejcts\/ezz325","article-title":"The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials","volume":"57","author":"Ng","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"B68","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1177\/02676591221106324","article-title":"Corticosteroids in patients undergoing cardiac surgery: a meta-analysis of 12,559 patients","volume":"38","author":"Chen","year":"2023","journal-title":"Perfusion"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0140-6736(15)00273-1","article-title":"Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Whitlock","year":"2015","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1053\/j.jvca.2024.07.001","article-title":"The effects of corticosteroids on survival in pediatric and nonelderly adult patients undergoing cardiac surgery: a meta-analysis of randomized studies","volume":"38","author":"Losiggio","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","article-title":"Cardioprotection: chances and challenges of its translation to the clinic","volume":"381","author":"Heusch","year":"2013","journal-title":"Lancet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1124\/pharmrev.121.000348","article-title":"Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia\/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning","volume":"75","author":"Ferdinandy","year":"2023","journal-title":"Pharmacol Rev"},{"key":"B73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischaemia\/reperfusion injury","volume":"73","author":"Davidson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11883-022-01078-8","article-title":"From \u201comics\u201d to multi-omics technologies: the discovery of novel causal mediators","volume":"25","author":"Mohammadi-Shemirani","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/ATVBAHA.122.318731","article-title":"Multiomics network medicine approaches to precision medicine and therapeutics in cardiovascular diseases","volume":"43","author":"Wang","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrg.2018.4","article-title":"Integrative omics for health and disease","volume":"19","author":"Karczewski","year":"2018","journal-title":"Nat Rev Genet"},{"key":"B77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barabasi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"100561","DOI":"10.1016\/j.mcpro.2023.100561","article-title":"Multi-omics profiling for health","volume":"22","author":"Babu","year":"2023","journal-title":"Mol Cell Proteomics"},{"key":"B79","doi-asserted-by":"publisher","first-page":"I275","DOI":"10.1161\/CIRCULATIONAHA.105.001032","article-title":"Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery","volume":"114","author":"Podgoreanu","year":"2006","journal-title":"Circulation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12872-019-1002-x","article-title":"Genome-wide association study of myocardial infarction, atrial fibrillation, acute stroke, acute kidney injury and delirium after cardiac surgery\u2014a sub-analysis of the RIPHeart-study","volume":"19","author":"Westphal","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"B81","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jtcvs.2011.12.022","article-title":"Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass","volume":"144","author":"Jouan","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B82","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13148-022-01414-4","article-title":"Longitudinal profiling in patients undergoing cardiac surgery reveals postoperative changes in DNA methylation","volume":"14","author":"Fischer","year":"2022","journal-title":"Clin Epigenetics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/cvr\/cvq082","article-title":"Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia\/reperfusion injury via anti-apoptosis through its target PDCD4","volume":"87","author":"Cheng","year":"2010","journal-title":"Cardiovasc Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e104618","DOI":"10.1371\/journal.pone.0104618","article-title":"Plasma levels of microRNA-499 provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients","volume":"9","author":"Yao","year":"2014","journal-title":"PLoS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/ALN.0000000000000582","article-title":"Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome","volume":"122","author":"Muehlschlegel","year":"2015","journal-title":"Anesthesiology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/clc.23443","article-title":"Preoperative soluble VCAM-1 contributes to predict late mortality after coronary artery surgery","volume":"43","author":"Corbalan","year":"2020","journal-title":"Clin Cardiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1038\/s41598-020-63051-2","article-title":"Prognostic role of serum high mobility group box 1 concentration in cardiac surgery","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.athoracsur.2018.04.084","article-title":"The association between novel biomarkers and 1-year readmission or mortality after cardiac surgery","volume":"106","author":"Jacobs","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e13953","DOI":"10.1111\/eci.13953","article-title":"Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery","volume":"53","author":"Koller","year":"2023","journal-title":"Eur J Clin Investig"},{"key":"B90","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","article-title":"Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS","volume":"515","author":"Chouchani","year":"2014","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41597-020-0545-0","article-title":"A longitudinal serum NMR-based metabolomics dataset of ischemia-reperfusion injury in adult cardiac surgery","volume":"7","author":"Maltesen","year":"2020","journal-title":"Sci Data"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.108.816116","article-title":"Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia\/reperfusion","volume":"119","author":"Turer","year":"2009","journal-title":"Circulation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/cvr\/cvab073","article-title":"New biomarkers from multiomics approaches: improving risk prediction of atrial fibrillation","volume":"117","author":"Kornej","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1016\/j.jacc.2017.03.571","article-title":"Artificial intelligence in precision cardiovascular medicine","volume":"69","author":"Krittanawong","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.jtcvs.2020.07.105","article-title":"Machine learning improves mortality risk prediction after cardiac surgery: systematic review and meta-analysis","volume":"163","author":"Benedetto","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B97","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jacc.2024.05.003","article-title":"Transforming cardiovascular care with artificial intelligence: from discovery to practice: JACC state-of-the-art review","volume":"84","author":"Khera","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e1028","DOI":"10.1161\/CIR.0000000000001201","article-title":"Use of artificial intelligence in improving outcomes in heart disease: a scientific statement from the American Heart Association","author":"Armoundas","year":"2024","journal-title":"Circulation"},{"key":"B99","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10822-026-00798-2","article-title":"AI-driven drug-target interaction prediction: current progress, challenges, and future roadmap for precision medicine","volume":"40","author":"Mondal","year":"2026","journal-title":"J Comput Aided Mol Des"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1365524","DOI":"10.3389\/fmed.2024.1365524","article-title":"Personalized anesthesia and precision medicine: a comprehensive review of genetic factors, artificial intelligence, and patient-specific factors","volume":"11","author":"Zeng","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41591-023-02401-9","article-title":"Integrated multi-omics for rapid rare disease diagnosis on a national scale","volume":"29","author":"Lunke","year":"2023","journal-title":"Nat Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/biom16020271","article-title":"Challenges and opportunities in multi-omics data acquisition and analysis: toward integrative solutions","volume":"16","author":"Hemme","year":"2026","journal-title":"Biomolecules"},{"key":"B103","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12911-020-01332-6","article-title":"Explainability for artificial intelligence in healthcare: a multidisciplinary perspective","volume":"20","author":"Amann","year":"2020","journal-title":"BMC Med Inform Decis Mak"},{"key":"B104","doi-asserted-by":"publisher","first-page":"103655","DOI":"10.1016\/j.jbi.2020.103655","article-title":"The role of explainability in creating trustworthy artificial intelligence for health care: a comprehensive survey of the terminology, design choices, and evaluation strategies","volume":"113","author":"Markus","year":"2021","journal-title":"J Biomed Inform"},{"key":"B105","doi-asserted-by":"publisher","first-page":"866","DOI":"10.7326\/M18-1990","article-title":"Ensuring fairness in machine learning to advance health equity","volume":"169","author":"Rajkomar","year":"2018","journal-title":"Ann Intern Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"111606","DOI":"10.1016\/j.jclinepi.2024.111606","article-title":"Sociodemographic bias in clinical machine learning models: a scoping review of algorithmic bias instances and mechanisms","volume":"178","author":"Colacci","year":"2025","journal-title":"J Clin Epidemiol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cardfail.2020.02.001","article-title":"Effects of elamipretide on left ventricular function in patients with heart failure with reduced ejection fraction: the PROGRESS-HF phase 2 trial","volume":"26","author":"Butler","year":"2020","journal-title":"J Card Fail"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1844417\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:57:05Z","timestamp":1788508625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1844417\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":107,"alternative-id":["10.3389\/fcvm.2026.1844417"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1844417","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1844417"}}